Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease — Azita H. Talasaz (2024) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease
Shared by
Professor Gregory Lip
University of Liverpool
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease
Article
2024
en
Authors
+33 more
AT
Azita H. Talasaz
PS
Parham Sadeghipour
LO
Luis Ortega‐Paz
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2013
Latest developments in antithrombotic therapy in patients with lower extremity arterial disease
Maria Beatrice Forte
,
Cecilia Becattini
,
Giancarlo Agnelli
Article
2018
Optimizing therapy in bortezomib-exposed patients with multiple myeloma
Magdalini Migkou
,
Maria Gavriatopoulou
,
Evangelos Terpos
,
Meletios A Dimopoulos
Letter
2022
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease
Ying X. Gue
,
Diana A. Gorog
,
Professor Gregory Lip
Article
1998
Antithrombotic Therapy for Venous Thromboembolic Disease
Thomas M. Hyers
,
Giancarlo Agnelli
,
Russell D. Hull
,
John G. Weg
,
Timothy A. Morris
,
Michel Samama
,
Victor F. Tapson
Article
2022
Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
So-Ryoung Lee
,
Jin‐Hyung Jung
,
Eue-Keun Choi
,
Seung‐Woo Lee
,
Soonil Kwon
,
Ji-Suck Park
,
Jeehoon Kang
,
Kyungdo Han
,
Kyung Woo Park
,
Seil Oh
,
Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.